Literature DB >> 20731760

Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures.

Gernot Kleinberger1, Hans Wils, Peter Ponsaerts, Geert Joris, Jean-Pierre Timmermans, Christine Van Broeckhoven, Samir Kumar-Singh.   

Abstract

Null mutations in progranulin (GRN) are associated with frontotemporal lobar degeneration characterized by intraneuronal accumulation of TAR DNA-binding protein-43 (TDP-43). However, the mechanism by which GRN deficiency leads to neurodegeneration remains largely unknown. In primary cortical neurons derived from Grn knockout (Grn(-/-) ) mice, we found that Grn-deficiency causes significantly reduced neuronal survival and increased caspase-mediated apoptosis, which was not observed in primary mouse embryonic fibroblasts derived from Grn(-/-) mice. Also, neurons derived from Grn(-/-) mice showed an increased amount of pTDP-43 accumulations. Furthermore, proteasomal inhibition with MG132 caused increased caspase-mediated TDP-43 fragmentation and accumulation of detergent-insoluble 35- and 25-kDa C-terminal fragments in Grn(-/-) neurons and mouse embryonic fibroblasts. Interestingly, full-length TDP-43 also accumulated in the detergent-insoluble fraction, and caspase-inhibition prevented MG132-induced generation of TDP-43 C-terminal fragments but did not block the pathological conversion of full-length TDP-43 from soluble to insoluble species. These data suggest that GRN functions as a survival factor for cortical neurons and GRN-deficiency causes increased susceptibility to cellular stress. This leads to increased aggregation and accumulation of full-length TDP-43 along with its C-terminal derivatives by both caspase-dependent and independent mechanisms.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731760     DOI: 10.1111/j.1471-4159.2010.06961.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

1.  Core features of frontotemporal dementia recapitulated in progranulin knockout mice.

Authors:  N Ghoshal; J T Dearborn; D F Wozniak; N J Cairns
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

Review 2.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

3.  Structure dissection of zebrafish progranulins identifies a well-folded granulin/epithelin module protein with pro-cell survival activities.

Authors:  Ping Wang; Babykumari Chitramuthu; Andrew Bateman; Hugh P J Bennett; Ping Xu; Feng Ni
Journal:  Protein Sci       Date:  2018-07-18       Impact factor: 6.725

Review 4.  Human genetics as a tool to identify progranulin regulators.

Authors:  Alexandra M Nicholson; NiCole A Finch; Rosa Rademakers
Journal:  J Mol Neurosci       Date:  2011-05-28       Impact factor: 3.444

5.  Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling.

Authors:  Jindong Xu; Maria Xilouri; Julien Bruban; Junichi Shioi; Zhiping Shao; Ioannis Papazoglou; Kostas Vekrellis; Nikolaos K Robakis
Journal:  Neurobiol Aging       Date:  2011-08-04       Impact factor: 4.673

6.  The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels.

Authors:  Dominique A Salazar; Victoria J Butler; Andrea R Argouarch; Tsung-Yuan Hsu; Amanda Mason; Ayumi Nakamura; Helen McCurdy; David Cox; Rachel Ng; Gloria Pan; William W Seeley; Bruce L Miller; Aimee W Kao
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

7.  Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices.

Authors:  Cadman Leggett; Daniel S McGehee; James Mastrianni; Wenbin Yang; Tao Bai; James R Brorson
Journal:  J Neurol Sci       Date:  2012-03-28       Impact factor: 3.181

8.  Progranulin Deficiency Reduces CDK4/6/pRb Activation and Survival of Human Neuroblastoma SH-SY5Y Cells.

Authors:  Ana de la Encarnación; Carolina Alquézar; Noemí Esteras; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2014-11-07       Impact factor: 5.590

9.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

10.  Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.

Authors:  Emily Feneberg; Petra Steinacker; Alexander Erich Volk; Jochen Hans Weishaupt; Marc Axel Wollmer; Adam Boxer; Hayrettin Tumani; Albert Christian Ludolph; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2015-12-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.